Skip to main content
EuroGCT
Menu
Close
Help and support
Help and support
FAQ's
Glossary
FAQ's
How is the safety of a new gene therapy determined?
How are gene and cell therapies different to 'traditional' therapies?
Where do embryonic stem cells for research come from?
How is the production of gene and cell therapies different to traditional treatments?
Why do we need gene and cell therapies? How are they different from traditional medicines and treatments?
What is genetic testing?
Is it ethical to use animals in health and scientific research?
What are the roles of regulators in the development of gene and cell therapies?
See all FAQs
Glossary
Accelerated assessment
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Advanced Therapy Investigational Medicinal Product (ATIMP)
Advanced Therapy Medicinal Product (ATMP)
Advertising
Antibody
See full Glossary
Search
Select language
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Select language
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Condition
Blood disorders
Sickle Cell Disease
Cardiovascular Disease
Heart Disease
Stroke
Bowel Disease
Cancer
Cystic Fibrosis
Eye Disease
Immune Conditions
Diabetes
Multiple Sclerosis
Kidney Disease
Liver Disease
Lung Disease
Bone and Muscle Conditions
Muscular Dystrophy
Spinal Cord Injuries
Neurological Disorders
Alzheimer's Disease
Cerebral Palsy
Huntington's Disease
Motor Neurone Disease
Parkinson's Disease
Spinal Muscular Atrophy
Skin
Epidermolysis Bullosa
Reproduction and Fertility
Theme
Cell and Gene Fundamentals
Blood Stem Cells
Cord Blood
Embryonic Stem Cells
iPS cells
MSCs
Skin Stem Cells
Current and Potential Uses
Cell Therapy
Gene Therapy
Clinical Trials
CAR-T Therapy
Methods and Tools
Disease Modelling
Organoids
Tissue Engineering
Gene Editing
Reprogramming
Ethics and Society
Patient Involvement
Policy & Regulation
Unproven Treatments
Spotlight on Research
Main navigation
Discover
Discover
Educational Resources Directory
INTENS
LEARN
Research Pathways
Research Pathways
EuroGCT Key Resources
ATMP Engage
CARTALLEU
Actors and Network database
About Us
Contact
Breadcrumb
Home
Ethics and Society
Ethics and Society
Resources & Factsheets
EuroGCT Resource
What are 'unproven' therapies?
Related Topics
Clinical Trials
Current and Potential Uses
Ethics and Society
Factsheets
MSCs
Policy & Regulation
Unproven Treatments
EuroGCT Resource
What are the roles of regulators in the development of gene and cell therapies?
Related Topics
Ethics and Society
Policy & Regulation
UK Citizens Jury on Human Embryo Editing
Related Topics
Reproduction and Fertility
Ethics and Society
Gene Editing
Policy & Regulation
English
EuroGCT Resource
Ethical questions in embryonic stem cell research
Related Topics
Embryonic Stem Cells
Current and Potential Uses
Ethics and Society
English
Growing support for gene and cell therapies in Germany
Related Topics
Cell Therapy
Ethics and Society
Gene Therapy
Policy & Regulation
International Guidelines for the Treatment of Huntington's Disease
Related Topics
Huntington's Disease
Neurological Disorders
Current and Potential Uses
Ethics and Society
Alzheimer's Society UK: Legal and financial issues for people living with dementia in the UK
Related Topics
Alzheimer's Disease
Neurological Disorders
Ethics and Society
Genetics Shambles
Related Topics
Cell and Gene Fundamentals
Ethics and Society
Explore Stem Cells
Gene Editing
Gene Therapy
Research
ATMP Engage working groups
Related Topics
Ethics and Society
Patient Involvement
Policy & Regulation
EuroGCT Resource
Why are some conditions more suitable for gene and cell therapies than others?
Related Topics
Current and Potential Uses
Cell Therapy
Gene Therapy
Clinical Trials
Methods and Tools
Disease Modelling
Gene Editing
Ethics and Society
Patient Involvement
Policy & Regulation
Research
Pagination
Page
1
Page
2
Page
3
Next page
››
Last page
Last »